Dilantin and Bacitracin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Bacitracin (bacitracin). Common drug interactions include mental status changes among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Dilantin and Bacitracin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.

What is Bacitracin?

Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.



On Jul, 11, 2026

13 people who take Dilantin and Bacitracin together, and have interactions are studied.

Dilantin and Bacitracin drug interactions.

What are the common drug interactions of Dilantin and Bacitracin, by gender? *:

female:

  1. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Mouth haemorrhage (bleeding from mouth)
  4. Mucosal inflammation (infection of mucous membrane)
  5. Multi-organ failure (multisystem organ failure)
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Myalgia (muscle pain)
  8. Myositis (inflammation of the muscles)
  9. Nausea (feeling of having an urge to vomit)
  10. Neck pain

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Difficulty in walking
  4. Disease progression
  5. Dry mouth
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. Fall
  9. Fear
  10. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

What are the common drug interactions of Dilantin and Bacitracin, by age (0-1 to 60+)? *:

0-1:

  1. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

2-9:

n/a

10-19:

  1. Anticonvulsant drug level decreased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

20-29:

  1. Hyperpyrexia (extremely high fever)
  2. Hypertension (high blood pressure)
  3. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Tachypnoea (a condition of rapid breathing over 20 per minute)
  6. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

30-39:

n/a

40-49:

n/a

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Cardiac arrest
  4. Depression
  5. Emotional distress
  6. Fear
  7. Injury
  8. Memory impairment
  9. Pain
  10. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Blood albumin decreased
  2. Bradycardia (abnormally slow heart action)
  3. Dry mouth
  4. Dyspnoea (difficult or laboured respiration)
  5. Fall
  6. Hypotension (abnormally low blood pressure)
  7. Metastases to central nervous system (cancer spreads to central nervous system)
  8. Metastases to lung (cancer spreads to lung)
  9. Nausea (feeling of having an urge to vomit)
  10. Neuropathy (damage to nerves)

What are the existing conditions these people have? *

  1. Rashes (redness): 4 people, 30.77%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 30.77%
  3. Wax Blockage: 3 people, 23.08%
  4. Teething (process by which an infant's first teeth grows): 3 people, 23.08%
  5. Nasal Dryness (dry nose): 3 people, 23.08%
  6. Body Temperature Increased: 3 people, 23.08%
  7. Stable Angina (a constant chest pain): 1 person, 7.69%
  8. Respiratory Disorder (respiratory disease): 1 person, 7.69%
  9. Pain: 1 person, 7.69%
  10. Operative Haemorrhage (bleeding due to surgery): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Bacitracin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilantin and Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bacitracin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and bacitracin (the active ingredients of Dilantin and Bacitracin, respectively), and Dilantin and Bacitracin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: